Daniel M. Rotroff, PhD of @CleClinicMD answers will this affect clinicians and treatment today on anti-PD-1/PD-L1 antibody immunotherapy.
_________
Read here:Â https://ascopubs.org/doi/full/10.1200/JCO.19.01712
Anti–PD-1/PD-L1 Antibody Immunotherapy: Will This Affect Clinicians Today?
